Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

FOSAPREPITANT FOR INJECTION DIN 02549379

Status: Marketed
Holder: JUNO PHARMACEUTICALS CORP.
Molecule: FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Health Canada record

Active ingredient(s)FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE) 150 MG
Dosage formPowder For Solution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCA04AD OTHER ANTIEMETICS
Original market date07-Aug-2025
Current status date07-Aug-2025
SourceHealth Canada DPD

Establishment licence of the holder

Juno Pharmaceuticals Corp. (now Juno Pharma Canada Inc.) — licence 3-002647, not currently licensed, last inspection rating C (2025-01-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

DINProductCompanyFormStrengthStatus
02363356EMEND IVMERCK CANADA INCPowder For SolutionFOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE) 150 MGMarketed
02436264FOSAPREPITANTAPOTEX INCPowder For SolutionFOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE) 150 MGApproved
02324679EMEND IVMERCK CANADA INCPowder For SolutionFOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE) 115 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
336322024-07-11Abbreviated New Drug Submission (ANDS)
Request a quote for FOSAPREPITANT FOR INJECTION

How to read a Canadian DIN record